# The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease

> **NCT00819338** · PHASE2 · COMPLETED · sponsor: **University of Nottingham** · enrollment: 58 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Efamax

## Key facts

- **NCT ID:** NCT00819338
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2012-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00819338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00819338, "The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00819338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*